-
x
x - 2018 Oral presentation
-
Using normal fat mass to account for body size and composition
Nick Holford - 2016 Oral presentation
-
A pilot study to investigate the relationship between doxorubicin and doxorubicinol pharmacokinetics and cardiotoxicity in children and adolescents with cancer
Stefanie Hennig - 2016 Poster presentation
-
Quantitative model diagrams (QMD): a new perspective in model evaluation
Benjamin Guiastrennec - 2016 Poster presentation
-
Understanding Identifiability of random effects in mixed effects models
Leon Aarons - 2016 Poster presentation
-
Dose selection for rifabutin in combination with HIV-protease inhibitors
Stefanie Hennig - 2016 Poster presentation
-
Using a PK/PD modeling approach to optimize the dosing regimen of secukinumab for the treatment of moderate to severe plaque psoriasis
Mick Looby - 2016 Oral presentation
-
Regulatory endorsed of M&S platforms: The case of Alzheimer Disease CTS
Klaus Romero - 2016 Oral presentation
-
Understanding the influence of vitamin K on warfarin dosing requirements
Qing-Xi Ooi - 2016 Oral presentation
-
Prediction of fat free mass in children
Hesham Al-Sallami - 2016 Oral presentation
-
Pharmacometric modelling of antimalarial drugs in development: from challenge to clinics
Nathalie Gobeau - 2016 Oral presentation
-
Road to individualising tacrolimus therapy in solid organ transplant recipients
Dr Christine Staatz - 2016 Oral presentation
-
Population Pharmacokinetic Analysis of Levetiracetam in Adult Malaysian Patients with Epilepsy
Yoke-Lin Lo - 2016 Poster presentation
-
Translation between two models; Application with integrated glucose homeostasis models
Moustafa Ibrahim - 2016 Poster presentation
-
nlmixr: an open-source package for pharmacometric modelling in R
Rik Schoemaker - 2016 Poster presentation
-
Comparison of non-compartmental analysis and non-linear mixed effects ability to determine bioequivalence in drugs with two-compartment kinetics
Jim Hughes - 2016 Poster presentation
-
Population modelling of functional disability in early rheumatoid arthritis treated according to a treat-to-target strategy
Jessica Wojciechowski - 2016 Poster presentation
-
Bayesian forecasting versus clinical practice for intravenous busulfan dose adjustment in paediatric stem cell transplantations
Lachlan Paterson - 2016 Poster presentation
-
NextDose: a web-based collaborative tool for target concentration intervention
Dr Sam Holford - 2016 Oral presentation
-
A viral kinetic model for severe human cytomegalovirus infections in immunocompromised paediatric patients
Mr Ben Margetts - 2016 Poster presentation
-
How Pharmacometrics can improve the power of pharmacogenetic studies
Julie Bertrand - 2016 Poster presentation
-
Advanced methods for dose finding during drug development: Summary of the EMA /EFPIA workshop on dose finding (London 4-5 December 2014)
Flora Musuamba Tshinanu - 2016 Oral presentation
-
Development of a Biomarker-based Prediction Model of Disease Progression during Chemotherapy in Young Adolescents
Young A Heo - 2016 Poster presentation
-
Mechanistic model for calcium treatment effect in calcium-parathyroid hormone homeostasis after thyroidectomy in Koreans.
Mijeong Son - 2016 Poster presentation
-
Imputation methods to correct overestimated shape parameter of Weibull hazard function in time-to-event modeling
Dong-Seok Yim - 2016 Poster presentation
-
Internal Deterministic Identifiability
Vijay Kumar Siripuram - 2016 Poster presentation
-
Simulation Analysis to Explore the Optimal Combination of Pregabalin and Duloxetine
Ah Ra Koh - 2016 Poster presentation
-
Pharmacokinetic and Pharmacodynamic Analysis of GCC-4401C, a Novel Direct Factor Xa Inhibitor, in Healthy Volunteers
Hyeong-Seok Lim - 2016 Poster presentation
-
Physiologically Based Pharmacokinetic Models for Trastuzumab Using Serial Concentrations Meausred By Optical Imaging in Mouse
Hyeong-Seok Lim - 2016 Poster presentation
-
Pharmacokinetic and Pharmacodynamic Modeling and Simulation Analysis of A Novel Donepezil Patch Formulation
Hyeong-Seok Lim - 2016 Poster presentation
-
Population Plasma and Urine Pharmacokinetics of Ivabradine and its Active Metabolite in Korean Healthy Volunteers
Hyeong-Seok Lim - 2016 Poster presentation
-
A simulation study to evaluate treatment effect of tamoxifen by CYP2D6 genotypes compared with AIs
Gwan Cheol Park - 2016 Poster presentation
-
Pharmacokinetic Modeling and Simulation Analysis of LCB01-0371, a New Oxazolidinone Antibiotic Under Clinical Development
Hyeong-Seok Lim - 2016 Poster presentation
-
Population Pharmacokinetics of Artesunate and Dihydroartemisinin in Patients with Sensitive and Resistant Malaria Infection
Thanaporn Wattanakul - 2016 Poster presentation
-
What purpose is the DDMoRe library serving?
Iñaki F. Trocóniz - 2016 Oral presentation
-
When statistics and pharmacometrics join forces for advanced quantitative drug development: A case study
Emmanuel Zuber - 2016 Oral presentation
-
Model-Based Meta-Analysis on the Efficacy of Pharmacological Treatments for Idiopathic Pulmonary Fibrosis
Phyllis Chan - 2016 Poster presentation
-
A population model for respiratory syncytial virus (RSV) kinetics using transit compartments based on human challenge data
Julia Korell - 2016 Oral presentation
-
Faster ADVAN-style analytical solutions for simulations from common pharmacokinetic models
Ahmad Y Abuhelwa - 2016 Poster presentation
-
A Quantitative Systems Pharmacology Model to Predict the Effects of Warfarin, Rivaroxaban and Enoxaparin on the Human Coagulation Network
Mirjam N. Trame - 2016 Poster presentation
-
Evaluation of Covariate Effect Size based on Parameter Variability
Takayuki Katsube - 2016 Poster presentation
-
Evaluation of linezolid-induced thrombocytopenia based on hospital pharmacometrics
Yasuhiro Tsuji - 2016 Oral presentation
-
How can users benefit from the DDMoRe common language standard and interoperability framework?
Phylinda LS Chan - 2016 Oral presentation
-
What advanced methods and algorithms are promoted through DDMoRe?
Andrew C. Hooker - 2016 Oral presentation
-
Pseudomonas aeruginosa eradication therapy predicts the hazard of having Aspergillus Fumigatus positive culture in early life of children with CF
Sabariah Noor Harun - 2016 Poster presentation
-
An optimal sampling schedule for neonates, infants & children receiving cefazolin +/- vancomycin for cardiopulmonary bypass
Jacqueline A Hannam - 2016 Poster presentation
-
Would a certification process for models published on the DDMoRe repository serve the modelling community?
Siv Jonsson - 2016 Oral presentation
-
Population pharmacokinetic model of pegylated interferon alfa-2a in healthy Korean male subjects
Yun Seob Jung - 2016 Poster presentation
-
Evaluation of intraocular penetration of levofloxacin after administration drop solution by high performance liquid chromatography and comparison with ciprofloxacin
Amir Heydari - 2016 Poster presentation
-
Application of continuous-time Marcov exposure-response model to sIGA. Nemolizumab case
Tomohisa Saito - 2016 Poster presentation
-
Population pharmacokinetic model of gentamicin in paediatric oncology patients.
Carolina Llanos-Paez - 2016 Poster presentation
-
Examining the predictive performance of different equations to estimate glomerular filtration rate in paediatric oncology patients.
Carolina Llanos-Paez - 2016 Poster presentation
-
Population of Pharmacokinetics of Tanezumab in Pateints with Chronic Low Back Pain
Rujia Xie - 2016 Poster presentation
-
Tofacitinib Pharmacokinetics in Moderate-to-Severe Crohn’s Disease Patients in Phase 2 Induction and Maintenance Studies
Chenhui Deng - 2016 Poster presentation
-
Application of a multi-criteria decision analysis model in the dose selection of combination therapy for overactive bladder
Mats O. Magnusson - 2016 Oral presentation
-
The population pharmacokinetics of OZ439 in healthy volunteers and patients with falciparum and vivax malaria
Piyanan (Jill) Assawasuwannakit - 2016 Poster presentation
-
Quantitative Review and Meta-models of Gastrointestinal pH to Help Inform Mechanistic Oral Absorption Models
Ahmad Y Abuhelwa - 2016 Poster presentation
-
Quantitative Review and Meta-models of Gastrointestinal Transit Times to Help Inform Mechanistic Oral Absorption Models
Ahmad Y Abuhelwa - 2016 Poster presentation
-
Mechanism-based modelling to assess suppression of bacterial resistance by high intensity, short duration tobramycin exposure
Vanessa E Rees - 2016 Poster presentation
-
A Framework for quantifying the influence of adherence and dose individualization
Piyanan (Jill) Assawasuwannakit - 2016 Oral presentation
-
Amikacin pharmacokinetics in Pediatric patients with burn injuries compared to those with oncology conditions
Catherine MT Sherwin - 2016 Poster presentation
-
Placebo effect in overactive bladder clinical studies: longitudinal model-based meta-analysis of micturitions
Chihiro Hasegawa - 2016 Poster presentation
-
Big world challenges for pharmacometrics
Mats O Karlsson - 2016 Oral presentation
-
Application of a quantitative systems pharmacology (QSP) model to evaluate xCT inhibition as a target for central nervous system diseases.
Mike Reed - 2016 Poster presentation
-
Challenges in treating infectious disease – linking epidemiology with pharmacometrics
Steven E. Kern - 2016 Oral presentation
-
Modeling and simulation with evolving cancer therapies: combinations, cancer immunotherapy, and more
Jin Jin - 2016 Oral presentation
-
The importance of body size for bridging studies
Masato Kaneko - 2016 Oral presentation
-
Population pharmacokinetics and pharmacodynamics of an oral glucagon receptor antagonist (LY2409021) and implications of patient dropout
Emmanuel Chigutsa - 2016 Oral presentation
-
A simple mechanistic pharmacometric model for HIV in children and adults
Joe Standing - 2016 Oral presentation
-
Why MIC is poison for the mind
Hartmut Derendorf - 2016 Oral presentation
-
Assessment of pharmacometric and statistical analysis methods in dose-finding trial design: application in diabetes drug development
Timothy Waterhouse - 2016 Oral presentation
-
Recommended doses of Levobupivacaine for TAP Blocks: Development of a pharmacokinetic model and estimation of the risk of symptoms of local anesthetic systemic toxicity
Luis Cortinez - 2016 Oral presentation
-
Developing next-generation malaria medicines to address drug resistance and increase the operational feasibility of malaria elimination efforts
David Reddy - 2016 Oral presentation
-
Pharmacometric modelling of antimalarial drugs in development
Joel Tarning - 2016 Oral presentation
-
Introduction to human challenge models for respiratory viruses and the application of quantitative pharmacology to enhance drug development
Craig R. Rayner - 2016 Oral presentation
-
Challenges and pitfalls of building models for Flu/RSV and respiratory viruses
Kashyap Patel - 2016 Oral presentation
-
Modeling tumor size and survival in patients with metastatic gastric cancer
Dong Woo Chae - 2016 Oral presentation
-
Pharmacometricians and statisticians in drug development: can’t we all just get along?
Stacey Tannenbaum - 2016 Oral presentation
-
Pharmacometrics, biostatistics and computational biology postgraduate training: how can we integrate courses?
Julie Simpson - 2016 Oral presentation
-
Application of a multi-criteria decision analysis model in the dose selection of combination therapy for overactive bladder
Mats O. Magnusson - 2016 Oral presentation
-
Bench-to-bedside translation of antibody drug conjugates (ADCs) using a multiscale mechanistic PK/PD model
Dhaval Shah - 2016 Oral presentation
-
Optimization of trial design and dose selection based on the quantitative assessment of the efficacy of TAK-385, an investigational, oral GnRH antagonist, in patients with prostate cancer
Nelleke Snelder - 2016 Oral presentation
-
An analysis of patient-reported outcomes (PRO) in breast cancer patients through item-response theory (IRT) pharmacometric modeling
Emilie Schindler - 2016 Oral presentation
Abstracts
Sort by: